Skip To Main Content
Barry W. Goy on Muck Rack

Barry W. Goy

As seen in: American Journal of Managed Care, OncLive, Targeted Oncology, Oncology Nursing News, Applied Radiation Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barry W.

Contact Barry W., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Benefits, Risks With EBRT Plus SADT in Intermediate-Risk Prostate Cancer

|
By Barry W. Goy
| Oncology Nursing News Verified
Though some factors like sexual function may be negatively affected, the addition of short-term neoadjuvant androgen deprivation therapy (SADT) may increase quality of life (QOL) for patients with intermediate-risk prostate cancer (IRPC), according to an oncologist.
Open in Who Shared Issue with article?

Unfavorable Intermediate- and High-Risk Prostate Cancer Treated With Predominantly Brachytherapy Alone With Long-Term Follow-Up

|
By Barry W. Goy, Aileen S. Baecker
| Applied Radiation Oncology
Published Date: December 1, 2023 By Barry W. Goy, MD; Aileen S. Baecker, PhD Abstract Objective: Assess 10-year outcomes of brachytherapy (BT) with or without supplemental external-beam radiation therapy (S-EBRT) for treatment of unfavorable intermediate-risk prostate cancer (U-IRPC) and high-risk prostate cancer (HRPC).
Open in Who Shared Issue with article?

Radiation Therapy Techniques in the Management of Locally Advanced, High-Grade, Soft-Tissue Sarcoma

|
By Barry W. Goy, Chris S. Helmstedter, Janis F. Yao, Sajjad P. Syed
| Applied Radiation Oncology
Case ReportBreastSarcoma/Cutaneous Tumors By Barry W. Goy, MD; Chris S. Helmstedter, MD; Janis F. Yao, MS; Sajjad P. Syed, MD Abstract Objective:We sought to assess which prognostic factors are associated with local recurrence (LR) rates and wound complications of locally advanced, high-grade, soft-tissue sarcoma (STS). Methods: Retrospective analysis was performed on patient data from 2005 to 2018, with high-grade STS of extremity or trunk, > 5 cm, histology-specific, with central pathology review.
Open in Who Shared Issue with article?
See all 7 licensed articles (11 Total)